Return to content in this issue
Efficacy of Mepolizumab Extended Interval Dosing For Two Asthmatic Cases with Chronic Eosinophilic Pneumonia
Sato H, Miyata Y Inoue H, Tanaka A, Sagara H
Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan
J Investig Allergol Clin Immunol 2021; Vol. 31(5)
doi: 10.18176/jiaci.0671
Key words: Chronic eosinophilic pneumonia, Mepolizumab, Anti-IL-5 monoclonal antibody, Asthma, Extended interval dosing
| Title | Type | Size | |
|---|---|---|---|
 |
10.18176_jiaci.0671_suppl-material.pdf | 283.16 Kb |
